1 |
34589661 |
10.1200/PO.21.00112 |
2022 |
Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma. |
FUBP1 |
2 |
35008187 |
10.3390/cancers14010023 |
2022 |
Low BACH2 Expression Predicts Adverse Outcome in Chronic Lymphocytic Leukaemia. |
FUBP1 |
3 |
35583604 |
10.1158/1078-0432.CCR-21-3347 |
2022 |
Interactome of Aiolos/Ikaros Reveals Combination Rationale of Cereblon Modulators with HDAC Inhibitors in DLBCL. |
FUBP1 |
4 |
36082445 |
10.1002/ijc.34278 |
2022 |
A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk. |
FUBP1 |
5 |
31467227 |
10.21873/cgp.20138 |
2020 |
Association of Leukemia Target Genes <i>Tet2, Bcl2</i>, and <i>Slc23a2</i> in Vitamin C Pathways. |
FUBP1 |
6 |
30500954 |
10.1093/nar/gky756 |
2019 |
Interplay between transcription regulators RUNX1 and FUBP1 activates an enhancer of the oncogene c-KIT and amplifies cell proliferation. |
FUBP1 |
7 |
27407063 |
10.1002/ijc.30263 |
2017 |
Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years. |
FUBP1 |
8 |
27599538 |
10.3892/mmr.2016.5718 |
2017 |
Expression of far upstream element binding protein 1 in B‑cell non‑Hodgkin lymphoma is correlated with tumor growth and cell‑adhesion mediated drug resistance. |
FUBP1 |